Binge Eating Clinical Trials 2024

What are the top hospitals conducting binge eating research?

In the battle against binge eating, several top hospitals are leading the way in innovative clinical trials. In Philadelphia, Drexel University's Stratton Hall is at the forefront with three active trials focused on this condition. Since their first recorded binge eating trial in 2018, they have made significant strides in understanding and treating this disorder. Meanwhile, also located in Philadelphia, Drexel University has two ongoing trials dedicated to binge eating and a commendable history of six completed studies since 2015.

Moving to New Haven, Connecticut, we find another powerhouse in binge eating research: the Yale Department of Psychiatry. With three active trials and four all-time trials under their belt since their groundbreaking study in 2007, Yale continues to make important contributions to our understanding of this complex disorder. Additionally adding itself to this list is Yale Medical School Department of Psychiatry where there's one experimental test currently underway; even though just launched last year(2022),it already showcases promising progress towards finding solutions for those affected by compulsive overeating.

Finally rounding out our list is Ohio's Lindner Center of HOPE situated within Mason with its focus on not only offering support but furthering knowledge through conducting eight such experiments investigating Binge Eating disorder interventions thus far ,their commitment culminate from starting back till first-ever record trial conducted by them dating back until2006

These outstanding institutions demonstrate a steadfast dedication to combating binge eating and improving the lives of those impacted by it. Through rigorous clinical research and compassionate care, these hospitals strive not only to alleviate symptoms but also provide hope for a future free from the chains of compulsive overeating

Which are the best cities for binge eating clinical trials?

When it comes to binge eating clinical trials, several cities offer opportunities for individuals seeking treatment and exploring new interventions. Philadelphia, Pennsylvania stands out with 5 active trials focused on various approaches like base self-help CBT programs combined with JITAIs and advanced digital data sharing with coaches. New Haven, Connecticut also presents promising options, including studies on LDX and cognitive behavioral therapy guided self-help. In Mason, Ohio, researchers are investigating morning light versions with melatonin and other potential treatments in 3 ongoing trials. Lastly, Hamilton, Ontario offers an active trial centered around a self-compassionate letter-writing intervention. These cities provide valuable resources to address binge eating disorders through research-driven methods tailored towards better patient outcomes.

Which are the top treatments for binge eating being explored in clinical trials?

In the realm of clinical trials, several treatments are being explored for binge eating. Topping the list is Behavioral Therapy for Eating Disorders, currently involved in one active trial and two all-time studies dedicated to binge eating since its listing in 2020. Another promising option is Cognitive behavioral therapy guided self-help (CBTgsh), which has just recently entered the scene with one active trial and one all-time study focused on treating binge eating starting from 2022. These innovative therapies hold great potential in providing effective solutions for individuals struggling with this disordered eating pattern.

What are the most recent clinical trials for binge eating?

Recent clinical trials have brought promising advancements in the treatment of binge eating disorder. One study focused on the efficacy of psychotherapy, showing positive results in addressing this condition. Additionally, a trial involving solriamfetol revealed its potential as a therapeutic option for individuals with binge eating disorder. Another investigation explored the combined use of morning light exposure and melatonin, indicating their beneficial effects on reducing binge eating episodes. Furthermore, naltrexone and bupropion were evaluated in separate phases to assess their effectiveness in managing this disorder. Lastly, phase 3 studies concerning lisdexamfetamine dimesylate (LDX) provided insights into its viability as a treatment option for those affected by binge eating disorder. These recent clinical trials offer hope for improved interventions that can alleviate the burden faced by individuals grappling with this condition.

What binge eating clinical trials were recently completed?

Several recent clinical trials have provided valuable insights into the treatment of binge eating disorder. In February 2021, Idorsia Pharmaceuticals successfully completed a trial investigating ACT-539313 as a potential therapy option. Yale University has also been at the forefront of research in this field, with several trials reaching completion in recent years. Their investigations into the effectiveness of Bupropion Hydrochloride and Naltrexone Hydrochoride Drug Combination concluded in April 2018. Furthermore, their studies on NB Medication (both acute treatment and Naltrexone Bupropion combination) wrapped up between September 2017 and August 2017. These important findings contribute to our understanding and offer hope for individuals struggling with binge eating disorder.